The oncologist Journal

Overview
Identity
View All

publication venue for

Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer.. 29:e1291-e1301. 2024
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.. 29:870-877. 2024
Recruitment of informal caregivers into community oncology research studies: results from the 2022 Landscape Assessment. 2024
Oncology drug pricing: potential Medicare savings on cancer-directed and supportive care medications through the Mark Cuban cost plus drug model.. 29:e918-e921. 2024
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.. 29:e351-e359. 2024
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.. 28:e1219-e1229. 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.. 28:e625-e632. 2023
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer.. 28:e488-e492. 2023
Specialty Differences in Medical Aid in Dying Experiences: Results of a Survey of Physicians in Colorado.. 28:e585-e587. 2023
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.. 28:494-500. 2023
A Systematic Review of Decision Aids in Hematologic Malignancies: What Are Currently Available and What Are We Missing?. 28:105-115. 2023
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology.. 27:778-789. 2022
Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life.. 27:694-702. 2022
Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).. 27:e494-e505. 2022
Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers.. 27:e37-e44. 2022
The Relationship Between Frailty and Emotional Health in Older Patients with Advanced Cancer.. 26:e2181-e2191. 2021
Association Between Caregiver-Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the Oncologist.. 26:e1992-e2001. 2021
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017.. 26:e1890-e1892. 2021
Patient-Reported Continuity of Care and Functional Safety Concerns After Inpatient Cancer Rehabilitation.. 26:887-896. 2021
Caregiver-Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life.. 26:310-317. 2021
Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.. 26:208-214. 2020
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.. 26:99-e217. 2020
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).. 26:e435-e444. 2020
Identifying Geriatric Oncology Competencies for Medical Oncology Trainees: A Modified Delphi Consensus Study.. 25:591-597. 2020
Opioid Prescribing Trends in Women Following Mastectomy or Breast-Conserving Surgery Before and After the 2014 Federal Reclassification of Hydrocodone.. 25:281-289. 2019
Associations of Polypharmacy and Inappropriate Medications with Adverse Outcomes in Older Adults with Cancer: A Systematic Review and Meta-Analysis.. 25:e94-e108. 2019
Risk of Osteoporosis and Fractures in Patients with Thyroid Cancer: A Case-Control Study in U.S. Veterans.. 24:1166-1173. 2019
Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.. 24:e828-e834. 2019
Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.. 24:e292-e302. 2019
Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).. 24:e284-e291. 2019
Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World Practice.. 24:e397-e399. 2019
Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.. 24:e828-e834. 2019
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.. 24:617-623. 2018
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.. 23:1388-1390. 2018
At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.. 23:1242-1249. 2018
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).. 23:1016-1023. 2018
Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.. 23:468-473. 2017
Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.. 21:165-71. 2015
Toxicity of bevacizumab in combination with chemotherapy in older patients.. 18:408-14. 2013
Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study.. 15:636-47. 2010
Polypharmacy in older adults with cancer.. 15:507-22. 2010
Never too old? Age should not be a barrier to enrollment in cancer clinical trials.. 10:198-204. 2005
The Matilda Effect: Under‐recognition of Women in Hematology and Oncology Awards 2021